RxDoctor Payments Data

Hassan Bencheqroun, MD

Critical Care Medicine · Palm Springs, CANPI 1174786594

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (36.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. GSK accounts for 76.1% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2019 at $2,753 and has fallen 98.3% since, to $47 in 2025.

$5,491in general payments, 2019–2025

Across 38 payments — averaging $144.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$4K
  • Advanced Respiratory, Inc$533
  • Johnson & Johnson$150
  • Bayer$125
  • United Therapeutics Corporation$123
  • Boston Scientific$120
  • plus $262 from 9 others
$55,887in research payments, 2019–2025

Across 25 payments — averaging $2235.48 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$26K
  • AstraZeneca$19K
  • Insmed, Inc.$10K
  • Novartis$1K

What the payments were for

  • Consulting fees$2,00036%
  • Travel & lodging$1,92735%
  • Food & beverage$1,56428%

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,491 in reported general payments places this provider in the 85th percentile of 715 critical care medicine providers in California.

See all critical care medicine providers in California

Medicare billing

Part B allowed, 2024
$221,809
Medicare patients
541
Services billed
1,253

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Palm Springs

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →